122 related articles for article (PubMed ID: 15131522)
21. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
De Deyn PP; Buitelaar J
Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.
Madhusoodanan S; Brenner R; Araujo L; Abaza A
J Clin Psychiatry; 1995 Nov; 56(11):514-8. PubMed ID: 7592504
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
24. The treatment of psychotic disorders in late life.
Thorpe L
Can J Psychiatry; 1997 Jun; 42 Suppl 1():19S-27S. PubMed ID: 9220126
[TBL] [Abstract][Full Text] [Related]
25. Role of risperidone in children with autism spectrum disorder.
Chavez B; Chavez-Brown M; Rey JA
Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
[TBL] [Abstract][Full Text] [Related]
26. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
Drach LM
Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015
[TBL] [Abstract][Full Text] [Related]
27. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
29. [Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders].
Bocharov AV; Kondakova VE; Tuleninov ES
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):25-31. PubMed ID: 22983233
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
Raheja RK; Bharwani I; Penetrante AE
J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):159-61. PubMed ID: 7576039
[TBL] [Abstract][Full Text] [Related]
31. [Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
Crocq MA; Camus V; Millet B; Gliskman J; Azorin JM; Krebs MO; Limosin F; Costentin J; Daléry J
Encephale; 2008 Apr; 34(2):187-93. PubMed ID: 18597728
[TBL] [Abstract][Full Text] [Related]
32. Outcome of risperidone therapy in elderly patients with chronic psychosis.
Sajatovic M; Ramirez LF; Vernon L; Brescan D; Simon M; Jurjus G
Int J Psychiatry Med; 1996; 26(3):309-17. PubMed ID: 8976471
[TBL] [Abstract][Full Text] [Related]
33. Risperidone for AIDS-associated dementia: a case series.
Belzie LR
AIDS Patient Care STDS; 1996 Aug; 10(4):246-9. PubMed ID: 11361596
[TBL] [Abstract][Full Text] [Related]
34. Does risperidone have a place in the treatment of nonschizophrenic patients?
Schweitzer I
Int Clin Psychopharmacol; 2001 Jan; 16(1):1-19. PubMed ID: 11195255
[TBL] [Abstract][Full Text] [Related]
35. Indications of atypical antipsychotics in the elderly.
McKean A; Monasterio E
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):5-7. PubMed ID: 25354148
[TBL] [Abstract][Full Text] [Related]
36. Optimal dosing with risperidone: updated recommendations.
Williams R
J Clin Psychiatry; 2001 Apr; 62(4):282-9. PubMed ID: 11379843
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of risperidone for treating patients with behavioral and psychological symptoms of dementia.
Wancata J
Int Psychogeriatr; 2004 Mar; 16(1):107-15. PubMed ID: 15191000
[TBL] [Abstract][Full Text] [Related]
38. Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease.
Duff K; Beglinger LJ; O'Rourke ME; Nopoulos P; Paulson HL; Paulsen JS
Ann Clin Psychiatry; 2008; 20(1):1-3. PubMed ID: 18297579
[TBL] [Abstract][Full Text] [Related]
39. Risperidone for the treatment of neuropsychiatric features in dementia.
Burns A; De Deyn PP
Drugs Aging; 2006; 23(11):887-96. PubMed ID: 17109567
[TBL] [Abstract][Full Text] [Related]
40. Neuropharmacological effect of risperidone: From chemistry to medicine.
Bhat AA; Gupta G; Afzal O; Kazmi I; Al-Abbasi FA; Alfawaz Altamimi AS; Almalki WH; Alzarea SI; Singh SK; Dua K
Chem Biol Interact; 2023 Jan; 369():110296. PubMed ID: 36496108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
